Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.

Treos Bio has tapped PPD to manage its first-in-human study on its lead cancer vaccine for colorectal cancer.

Greenphire integrates its patient payment solution into mProve's patient engagement mobile app.

Outcome Health has tapped Harvard Health Publications to improve and expand its health intelligence offerings.

Arcus inked an $816 million deal for a PD-1 drug developed by Chinese firms WuXi Biologics and Gloria Pharmaceuticals.

DNA-encoded library technology expert HitGen just inked a multiyear, multitarget drug discovery deal with Aduro Biotech.

After months of rumors and amid a larger flurry of CRO M&A activity, LabCorp has bought out U.K. CRO Chiltern.

BeiGene is adding Medidata’s electronic patient-reported outcome solution to oncology clinical studies.